Overall, these data support KRAS, ICAM-1, and inflammation as contributors to pancreatic ductal adenocarcinoma by initiation and acceleration of acinar-ductal metaplasia [45]. Here, KRAS is linked to pancreatic ductal adenocarcinoma.